Drug Interactions

Drug interactions between Dilantin and Topamax

Results for the following 2 drugs:

Dilantin (phenytoin)
Topamax (topiramate)

Interactions between your selected drugs

phenytoin ⇔ topiramate

Applies to: Dilantin (phenytoin) and Topamax (topiramate)

MONITOR: Topiramate administered with phenytoin has been reported to have led to a 25% increase in phenytoin plasma concentrations, particularly in those patients receiving phenytoin twice a day. Additionally, the concentration of topiramate decreased by 48%. Topiramate may decrease the metabolism of phenytoin (or other hydantoins) while hydantoins may increase the metabolism of topiramate.

MANAGEMENT: Patients should be closely observed for clinical response and signs of hydantoin toxicity if these drugs must be given concurrently and serum concentrations should be monitored. Patients should be advised to notify their physician if they experience loss of seizure control or symptoms of hydantoin toxicity, including drowsiness, visual disturbances, change in mental status, seizures, nausea, or ataxia. Addition or withdrawal of hydantoins during therapy with topiramate may require a dose adjustment of topiramate and/or the hydantoin.

See also...




Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. Multum's drug information does not endorse drugs, diagnose patients, or recommend therapy. Multum's drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2009 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.


MedNotes
Advertisement

(web3)